US 12049630
Factor XII (F12) iRNA compositions and methods of use thereof
granted A61KA61K47/549
Quick answer
US patent 12049630 (Factor XII (F12) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K47/549